Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator

Human Immunology
Xiao Ming FengZhong Chao Han

Abstract

Interleukin-27 (IL-27) is a novel IL-12 family member that plays a critical role in the regulation of T-cell responses. Its immunoregulatory effects on endothelial cells (EC) remain unexplored. Here we show a role for IL-27 in the induction of major histocompatibility complex (MHC) expression in primary human EC. Stimulation of human umbilical vein ECs by IL-27 rapidly induces IFN regulatory factor-1 and dramatically increases the expression of major histocompatibility class II transactivator (CIITA) isoform IV. Expression of this transactivator correlates with increased MHC class II gene expression. IL-27 also enhances expression of MHC class I molecules. Furthermore expression of beta2-microglobulin and transporter associated with antigen processing-1 transcripts increases in response to IL-27. Additional microarray analysis demonstrates that IL-27 significantly upregulates a panel of genes that correlates with immune regulation, including the chemokines CXCL9, CXCL10, and CX3CL1 in human umbilical vein ECs. This first demonstration that both MHC II and I expression are increased in EC after IL-27 stimulation suggests that IL-27 may be important in conferring immune function on vascular endothelium.

References

Jan 1, 1994·Critical Reviews in Immunology·P Le Bouteiller
Feb 1, 1995·The Journal of Experimental Medicine·C H Chang, R A Flavell
Jan 1, 1996·Annual Review of Immunology·B MachW Reith
Feb 22, 2001·Human Immunology·G L PalmisanoG B Ferrara
May 9, 2001·The Journal of Clinical Investigation·P FraticelliA Mantovani
May 2, 2002·Cell·Jenny Pan-Yun Ting, John Trowsdale
Jan 22, 2004·Current Opinion in Immunology·Peter J van den ElsenNienke van der Stoep
May 27, 2004·European Journal of Immunology·Salomé LeibundGut-LandmannWalter Reith
Jan 18, 2005·Current Opinion in Immunology·Lars Karlsson
Feb 13, 2007·Annual Review of Immunology·Robert A KasteleinDaniel J Cua

❮ Previous
Next ❯

Citations

Sep 28, 2010·Archivum Immunologiae Et Therapiae Experimentalis·Marek JankowskiAnna Goc
Sep 14, 2013·Human Gene Therapy·Olga ZolochevskaMarxa L Figueiredo
Jun 29, 2012·Journal of Neuroinflammation·Ursula PüntenerJessica L Teeling
May 7, 2014·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Christopher WynickKatrina Gee
Jul 15, 2009·International Immunopharmacology·Seetharamaiah ChittiprolBangalore N Gangadhar
Mar 5, 2013·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Sebastian Rune NielsenKaterina Tritsaris
Oct 5, 2010·Scandinavian Journal of Immunology·J P LiZ C Han
Oct 23, 2012·Journal of Cellular Physiology·Olga ZolochevskaMarxa L Figueiredo
Dec 15, 2015·Mediators of Inflammation·Susann A DoroszJean-Luc Bueb
Jan 12, 2013·Trends in Molecular Medicine·Gopal Murugaiyan, Bhaskar Saha
Dec 27, 2011·Vascular Pharmacology·Svitlana DemyanetsJohann Wojta
Mar 29, 2008·Journal of Intensive Care Medicine·Randeep S JawaMahmoud N Kulaylat
Jan 7, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alessandra VultaggioPaola Parronchi
Nov 5, 2019·Frontiers in Oncology·Olena KourkoKatrina Gee
Mar 4, 2017·Mediators of Inflammation·Marina FabbiSilvano Ferrini
Sep 24, 2020·Immunology·Cornelia HeubergerKevin Joseph Maloy
Jul 1, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Claudia CoccoIrma Airoldi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.